Atlas Trials

A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months

Clinical trial NCT06622109 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06622109
Sponsor
Pfizer
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Pneumococcal Disease
Start date
2024-11-25
Primary completion
2026-12-15
Enrollment
1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.